Difference in the Prognostic Significance of N-Terminal Pro-B-Type Natriuretic Peptide between Cardioembolic and Noncardioembolic Ischemic Strokes

Table 3

Univariate and multivariate predictors of mortality and functional outcome in patients with a cardioembolic source; odds ratio (95% confidence interval).

Variables	Mortality		Functional outcome
	Univariate	Multivariate	Univariate	Multivariate
Age	1.036 (1.004–1.069)		0.958 (0.936–0.981)
Female gender			0.486 (0.273–0.863)
LV systolic dysfunction	4.400 (2.009–9.638)	2.963 (1.068–8.220)	0.367 (0.193–0.699)
NT-proBNP	12.614 (3.713–42.853)	4.297 (1.073–17.203)	0.199 (0.106–0.373)
Creatinine	1.464 (1.116–1.920)	1.489 (1.063–2.085)
NIHSS at admission	1.131 (1.082–1.182)	1.125 (1.067–1.185)	0.810 (0.769–0.854)	0.802 (0.754–0.854)

LV: left ventricular; NT-proBNP: N-terminal pro-B-type natriuretic peptide; NIHSS: National Institutes of Health Stroke Scale.